4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001209191-22-006384
Chief Medical Officer sold 1,374 shares at $7.58 ($10,415)
- Chief Medical Officer acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schoenberg Mark · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-31 | Exercise or conversion : show line 1 in the form | +500 | 22,595 | D | ||
| 2022-01-31 | Sale : show line 2 in the form | −275 | $7.58 | $2,085 | 22,320 | D |
| 2022-01-31 | Exercise or conversion : show line 3 in the form | +2,000 | 24,320 | D | ||
| 2022-01-31 | Sale : show line 4 in the form | −1,099 | $7.58 | $8,330 | 23,221 | D |
| Open-market sales · 1,374 sh · avg $7.58 · $10,415 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-01-31 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −500 | 500 | 2,000 | D | ||
| 2022-01-31 | Grant or award : show line 6 in the form Stock Option (right to buy) | +12,064 | $7.72 | 2032-01-31 | 12,064 | 12,064 | D |
| 2022-01-31 | Grant or award : show line 7 in the form Restricted Stock Units | +4,000 | 0 | 4,000 | D | ||
| 2022-01-31 | Exercise or conversion : show line 8 in the form Restricted Stock | −2,000 | 2,000 | 4,000 | D |
Loading xslF345X03/doc4.xml…